Endocrine Abstracts

Introduction: European Neuroendocrine Tumour Society guidelines advocate the use of platinum-based chemotherapy in combination with Etoposide as first line chemotherapy in advanced GEP-NEC. Following this regime, 30% of digestive NEC and 60% of colorectal NEC showed a lack of benefit or evidence of disease progression. Available retrospective evidence is from small studies. Other studies have shown BMI relates to survival in NEN. This study aims at studying chemotherapy regime...